SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

WHWK

Whitehawk Therapeutics, Inc.
NASDAQHealth Care

Latest close: 2.89 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 10, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 6, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record63227 flagged findings
Reported transactions (Form 4)80since Aug 5, 2024 · and 5 other holdings
Corporate events (8-K)30since Aug 27, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as AADI.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-13share offering or dilution eventrecentOpen filing ↗
    “…Investors”), pursuant to which the Company agreed to sell to the PIPE Investors (i) 4,330,866 shares of the Company’s common stock,…”
    +1 more passage from the same document
    • “…price of $3.9199 per Pre-Funded Warrant, for an aggregate purchase price of $87,500,000 (collectively, the “PIPE Financing”). The…”
  • 2026-05-07share offering or dilution eventrecentOpen filing ↗
    “…with certain investors (the “2022 PIPE Investors”) for the sale by the Company of (i) 3,373,526 shares of the Company’s common…”
    +1 more passage from the same document
    • “…common stock, par value $ 0.0001 per share, at a purchase price of $ 2.40 per share, and (ii) pre-funded warrants to purchase…”
  • 2026-05-07listing compliance noticerecentOpen filing ↗
    “…Regardless of the merits or the ultimate results of such litigation, if instituted, such litigation could result in…”
    +1 more passage from the same document
    • “…circumstances differ from our assumptions, estimates or judgements, our operating results may be adversely affected and could fall…”
  • 2026-05-07export control restrictionsrecentOpen filing ↗
    “…into the United States. Tariffs, trade restrictions or sanctions imposed by the United States or other countries, including as…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 632)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 5 Form 4/A filingsshow all 5hide
  • Insider transaction · 6 Form 4 filingsshow all 6hide
  • Sep 11, 26Form 3 ↗Insider transaction
  • Sep 10, 268-K ↗Current report · A senior executive left or was appointed
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Fan Yu · 9.4% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · OrbiMed Advisors LLC · 7.3% · event on Jun 30, 26 · amendment
  • Aug 6, 2610-Q ↗Quarterly report
  • Aug 6, 268-K ↗Current report · Results
  • Insider transaction · 8 Form 4 filingsshow all 8hide

632 filings on record, the oldest from Apr 4, 08.

Listing the 25 most recent filings of the 632 on record.

8-Ks, explained

Stress6Structure28Governance30
  • Sep 10, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • May 13, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Mar 26, 25StructureCompleted an acquisition or disposal+1 more in the same filing8-K 2.01 ↗
  • Mar 4, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Dec 20, 24StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Sep 19, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Aug 22, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 21, 24StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Apr 4, 24StructureEntered a material agreement8-K 1.01 ↗
  • Governance4 senior executive changes2023show all 4hide
    • Oct 2, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Mar 28, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Mar 28, 23GovernanceA senior executive left or was appointed8-K/A 5.02 ↗
    • Mar 3, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 23, 23StructureEntered a material agreement8-K 1.01 ↗
  • Nov 28, 22StressListing notice (8-K 3.01)8-K 3.01 ↗

10 older filings not shown · The record reaches back to Mar 13, 17.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Feb 1, 21StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Jan 27, 20StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jul 26, 19StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 4, 19StressRestructuring plan with committed costs8-K 2.05 ↗

The full record holds 6 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Avoro Capital Advisors LLC20.0%May 12, 26SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • BEHZAD AGHAZADEH20.0%Feb 28, 25SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • ANUPAM DALAL9.0%May 14, 26SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Leonard Braden Michael5.0%Mar 5, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings
  • Neil Desai4.9%Mar 4, 25SCHEDULE 13D/A ↗1 earlier filing

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • SUVRETTA CAPITAL MANAGEMENT, LLC10.0%Mar 4, 25SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Fan Yu9.4%Jun 30, 26SCHEDULE 13G/A ↗13 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • QVT Financial LP9.4%Dec 31, 24SCHEDULE 13G ↗
  • OrbiMed Advisors LLC7.3%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Point72 Asset Management, L.P.6.0%Jan 22, 25SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
show 2 more holdershide
  • Coastlands Capital LP6.0%Aug 19, 25SCHEDULE 13G ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
  • EcoR1 Capital, LLC1.4%Dec 31, 24SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Apr 16, 26Sell$585KScott M. GiacobelloCHIEF FINANCIAL OFFICER↗
  • Apr 15, 26Sell$297KScott M. GiacobelloCHIEF FINANCIAL OFFICER↗
  • Apr 14, 26Sell$337KBRYAN BALLSee remarks↗
  • Apr 13, 26Sell$91KBRYAN BALLSee remarks↗
  • Apr 10, 26Sell$23KBRYAN BALLSee remarks↗
  • Apr 9, 26Sell$49KDavid James LennonCHIEF EXECUTIVE OFFICER↗
  • Apr 9, 26Sell$179KBRYAN BALLSee remarks↗
  • Apr 8, 26Sell$217KDavid James LennonCHIEF EXECUTIVE OFFICER↗
  • Apr 7, 26Sell$323KDavid James LennonCHIEF EXECUTIVE OFFICER↗
  • Apr 6, 26Sell$359KDavid James LennonCHIEF EXECUTIVE OFFICER↗
  • Apr 2, 26Sell$93KDavid James LennonCHIEF EXECUTIVE OFFICER↗
  • Mar 2, 26Sell$9KScott M. GiacobelloCHIEF FINANCIAL OFFICER↗

There are 8 more transactions in this stretch.

Stock compensation, tax and giftsshow the 20 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • May 14, 26Compensation$1000KCaley Castelein↗
  • May 14, 26Compensation$150KScott M. GiacobelloCHIEF FINANCIAL OFFICER↗
  • May 14, 26Compensation$200KBRYAN BALLSee remarks↗
  • May 14, 26Compensation$75KMargaret DuganChief Medical Officer↗
  • May 14, 26Compensation$200KDavid James LennonCHIEF EXECUTIVE OFFICER↗
  • May 14, 26Compensation$5.0MAnupam Dalal↗
  • Apr 1, 26Compensationamount n/aScott M. GiacobelloCHIEF FINANCIAL OFFICER↗
  • Apr 1, 26Compensationamount n/aBRYAN BALLSee remarks↗
  • Apr 1, 26Compensationamount n/aDavid James LennonCHIEF EXECUTIVE OFFICER↗
  • Mar 1, 26Compensationamount n/aScott M. GiacobelloCHIEF FINANCIAL OFFICER↗
  • Mar 1, 26Compensationamount n/aBRYAN BALLSee remarks↗
  • Mar 1, 26Compensationamount n/aDavid James LennonCHIEF EXECUTIVE OFFICER↗
  • Mar 4, 25Compensation$240KBRYAN BALLSee remarks↗
  • Mar 4, 25Compensation$3.0MBaiteng Zhao↗
  • Mar 4, 25Compensation$4.0MCaley Castelein↗
  • Mar 4, 25Compensation$3.7MAnupam Dalal↗
  • Mar 1, 25Compensationamount n/aDavid James LennonCHIEF EXECUTIVE OFFICER↗
  • Mar 1, 25Compensationamount n/aScott M. GiacobelloCHIEF FINANCIAL OFFICER↗
  • Mar 1, 25Compensationamount n/aBRYAN BALLSee remarks↗
  • Oct 2, 24Compensationamount n/aDavid James LennonCHIEF EXECUTIVE OFFICER↗

The full record holds 81 transactions and goes back to Jan 3, 23.

Its sector and its market

Whitehawk Therapeutics, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Whitehawk Therapeutics, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Whitehawk Therapeutics, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
632 documents on file, from Apr 4, 2008 to Sep 18, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.